Episode
Inhalable, Room-Temp, Needle-Free: Immuno‑Nanomed's Vaccine Moonshot
- Podcast
- Iowa Tech Podcast
- Published
- Feb 10, 2026
- Duration seconds
- 1629
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/iowa-tech-podcast-7097920/episodes/inhalable-room-temp-needle-free-immuno-nanomed-s-vaccine-moonshot/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/iowa-tech-podcast-7097920/inhalable-room-temp-needle-free-immuno-nanomed-s-vaccine-moonshot.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
On this episode of the Iowa Tech Podcast, host Kaylee sits down with Dr. Balaji Narasimhan, CEO and founder of ImmunoNanoMed, to explore a moonshot innovation: a dry-powder, needle-free vaccine platform called "powder wax" that's inhaled through the nose. Balaji explains how their particle-based technology could deliver stronger, faster mucosal immunity right where respiratory pathogens take hold, improve protection against variants, and eliminate the cold chain—potentially slashing costs and enabling at-home, self-administered vaccination. He also shares how the platform could multiplex vaccines (think flu, RSV, COVID, pneumonia) and extend to companion animals and even livestock and poultry via mass-vaccination approaches, with an eye toward DIVA compatibility and safeguarding human health supply chains. 💡 Find this show on your favorite player: https://iowapodcast.com/immunonanomed... 🗞️ Be first to get new interviews: https://iowapodcast.com/subscribe/ 🐖 Get a free $30 gift card from Jethro's BBQ: https://iowapodcast.com/jethrosbbq Balaji traces the technology's origins to a Seahawk collaboration between Iowa State University and the University of Iowa, then details ImmunoNanoMed's path from lab success to commercialization: building a cross-functional team, partnering with CROs to get FDA-ready, pursuing scalable, high-quality manufacturing, and engaging potential big-pharma partners—all targeted over the next 6–18 months. He reflects on Iowa's innovation ecosystem (Startup Factory, I-Corps, IEDA, InnoVenture) and why he's committed to proving world-class health tech can emerge from the Midwest. The episode closes with personal notes on mentors, teamwork, and family, plus a call for collaborators. Learn more or get in touch at immunonanomed.com. Chapters: 00:00 In…